EUVIMEDEUVIMED entdecken
Systematische ÜbersichtUmbrella Review

Gabapentinoids and Neuropathic Pain: Evaluation of the Quality of Randomised Controlled Trials: An Umbrella Review

Humbert de Freminville, Laura Lucatelli, Marc Chanelière, Guillaume Grenet, Sabine Mainbourg, Rémy Boussageon iD

Fundamental & Clinical Pharmacology · 2026

DOI: 10.1111/fcp.70052 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Fundamental & Clinical Pharmacology, 2026. Verfasst von Humbert de Freminville und 5 weiteren Autor:innen. Beteiligte Einrichtung: Collège Universitaire de Médecine Générale, UCBL Lyon 1, Lyon, France. Hauptthemen laut MEDLINE: Neuralgia, Randomized Controlled Trials as Topic, Gabapentin, Analgesics. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain remains a complex condition to manage. While current literature provides best practice guidelines for the use of gabapentinoids in this indication, these recommendations are primarily based on randomised clinical trials (RCTs) and meta‐analyses of varying methodological quality. To support evidence‐based prescribing, we conducted an evaluation of the overall confidence in meta‐analytic findings on the efficacy of gabapentinoid in adults. A systematic review of the meta‐analyses of RCTs retrieved from the MEDLINE (PubMed) database was performed. The methodological quality of these meta‐analyses was assessed using the AMSTAR 2 tool (A MeaSurement Tool to Assess systematic Reviews) and compared when available with the quality of evidence determined by the GRADE approach. Among the 16 included meta‐analyses, 14 were rated as having ‘critically low’ quality, one as ‘low’ and one as ‘moderate’ according to AMSTAR 2. GRADE and AMSTAR 2 assessments were both available for six meta‐analyses, but only one yielded a concordant result. According to AMSTAR 2, the highest‐quality meta‐analysis was the one published in the Cochrane Database of Systematic Reviews and concluded that more participants had substantial benefit (at least 50% pain relief or patient global impression change very much improved) with gabapentin at 1200 mg daily or greater than with placebo (in postherpetic neuralgia: RR = 1.8 [95% CI 1.5 to 2.1] and in painful diabetic neuropathy: RR = 1.9 [95% CI 1.5 to 2.3]). One limitation of this work is the inconsistent use of the term neuropathic pain, which may be defined differently across studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaRandomized Controlled Trials as TopicGabapentinAnalgesicsHumansMeta-Analysis as Topic

Stichwörter der Autor:innen

AMSTAR 2gabapentinneuropathic painpainful diabetic neuropathypostherpetic neuralgiapregabalin

Substanzen

GabapentinAnalgesics

Autor:innen und Institutionen

  • Collège Universitaire de Médecine Générale, UCBL Lyon 1, Lyon, France.
  • RESHAPE, Inserm U1290, Lyon, France.
  • UMR 5558, LBBE, EMET, CNRS, Université Claude Bernard Lyon 1, Lyon, France.
  • P2S, UR 4129, Université Claude Bernard Lyon 1, Lyon, France.

ORCID-Profile: Rémy Boussageon

Zitieren

APA

de Freminville, H., Lucatelli, L., Chanelière, M., Grenet, G., Mainbourg, S., & Boussageon, R. (2026). Gabapentinoids and Neuropathic Pain: Evaluation of the Quality of Randomised Controlled Trials: An Umbrella Review. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70052

Vancouver

de Freminville H, Lucatelli L, Chanelière M, Grenet G, Mainbourg S, Boussageon R. Gabapentinoids and Neuropathic Pain: Evaluation of the Quality of Randomised Controlled Trials: An Umbrella Review. Fundamental & Clinical Pharmacology. 2026. doi:10.1111/fcp.70052

BibTeX
@article{deFreminville2026,
  author = {de Freminville, Humbert and Lucatelli, Laura and Chanelière, Marc and Grenet, Guillaume and Mainbourg, Sabine and Boussageon, Rémy},
  title = {Gabapentinoids and Neuropathic Pain: Evaluation of the Quality of Randomised Controlled Trials: An Umbrella Review},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2026},
  doi = {10.1111/fcp.70052}
}
Kostenlos starten →